Mayinglong Pharmaceutical Group Co., Ltd. (SHA:600993)

Market Cap	11.20B +8.3%
Revenue (ttm)	3.77B +8.4%
Net Income	571.60M +18.5%
EPS	1.33 +18.8%
Shares Out	431.05M
PE Ratio	19.52
Forward PE	17.15
Dividend	0.62 (2.37%)
Ex-Dividend Date	Aug 8, 2025

Volume	3,191,005
Average Volume	3,555,463
Open	25.85
Previous Close	25.98
Day's Range	25.52 - 25.91
52-Week Range	24.24 - 31.46
Beta	0.41
RSI	34.52
Earnings Date	Apr 25, 2026

About SHA:600993

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. The company offers functional cosmetics, functional care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells medicinal packaging materials, cosmetics, and Chinese medicines; and offers first and second category medical devices, household products, electronic products, daily necessities, hygiene products, and disinfection products, as...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1582
• Employees: 2,654
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600993

Financial Performance

In 2024, SHA:600993's revenue was 3.73 billion, an increase of 18.85% compared to the previous year's 3.14 billion. Earnings were 528.09 million, an increase of 19.14%.